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Abstract
Parkinson’s disease (PD) is one of the main causes of neurological disability in the elderly.
Levodopa is the gold standard for treating this disease, but chronic levodopa therapy is complicated
by motor fluctuation and dyskinesia. The catechol-O-methyltransferase (COMT) inhibitors rep-
resent a new class of antiparkinsonian drugs. When coadministered with levodopa/decarboxylase
inhibitor, 2 COMT inhibitors, tolcapone and entacapone have been shown to improve the clinical
benefit of levodopa. COMT activity is genetically polymorphic, and individuals with the low activ-
ity (COMT(L/L)) genotype have a thermolabile COMT protein; studies suggest that this genotype
is less common in Asians than in Caucasians. Differences in COMT activity may determine the
individual response to levodopa and result in ethnic differences in PD susceptibility. Our recent
study suggests that the COMTL allele can interact with the MAOB gene to increase the occurrence
of PD in Taiwanese. In order to understand this new class of antiparkinsonian drugs, we review
their basic properties, pharmacology, and clinical efficacy. The frequency distribution of COMT
genetic polymorphisms among different populations and its implications in the etiology and drug
response is also discussed.
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